Research Article

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes

Table 4

Univariate and multivariate analysis for prediction of visual outcomes at 60 months.

Variables at baselineBCVA scoreΔBCVA scoreBCVA score ≥ 65ΔBCVA score> 0
Univariate analysis ( value)Multivariable analysis ( value)Univariate analysis ( value)Multivariable analysis ( value)Univariate analysis ( value)Multivariable analysis ( value)Univariate analysis ( value)Multivariable analysis ( value)

Gender0.8420.0390.2460.1610.2510.0130.014
Age0.0470.6170.1090.2000.7700.0880.016
Treatment delay0.1510.0090.8390.795
Baseline BCVA<0.001<0.001<0.001<0.001<0.0010.0010.004<0.001
CNV lesion subtype0.0020.8010.0780.990
CFT0.0030.2180.9070.1480.7810.702
Subfoveal hemorrhage0.9570.9201.0000.748
Subretinal fibrosis0.8200.2120.6810.731
Variables during follow-up
Number of CNV-ME0.0170.5330.3020.0140.0840.259
Number of missed CNV-ME0.8220.9010.9190.980
Number of injections0.0020.0140.4010.2630.0600.018
Number of missed injections0.0640.2530.6760.6300.1600.233
Number of treatment suspensions0.0780.9600.9570.0700.9540.400
Development of atrophy0.1130.7450.3260.6250.221
Development of RPE tear0.1200.2260.8300.2040.731
Development of subretinal fibrosis<0.0010.0120.2240.0520.1230.512
Number of sudden massive hemorrhages<0.0010.0750.2890.0170.3060.278

BCVA: best-corrected visual acuity; Δ: variation; CNV: choroidal neovascularization; CFT: central foveal thickness; CNV-ME: choroidal neovascularization medical examination; RPE: retinal pigment epithelium; value was from the following: independent samples Mann–Whitney U test; one-way ANOVA; independent-sample t-test. Pearson chi-square; linear-by-linear association; binomial logistic regression; Fisher’s exact test; variables with in univariate analysis were included in the multivariable analysis; variables with in multivariable analysis were included in the final multivariable model for predictive factors of designated outcome.